- Home
- REPL vs PSBD Comparison
REPL vs PSBD Comparison
Compare REPL & PSBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- PSBD
- Stock Information
- Founded
- REPL 2015
- PSBD 2009
- Country
- REPL United States
- PSBD United States
- Employees
- REPL N/A
- PSBD N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- PSBD
- Sector
- REPL Health Care
- PSBD
- Exchange
- REPL Nasdaq
- PSBD Nasdaq
- Market Cap
- REPL 547.0M
- PSBD 454.5M
- IPO Year
- REPL 2018
- PSBD 2024
- Fundamental
- Price
- REPL $5.56
- PSBD $13.93
- Analyst Decision
- REPL Buy
- PSBD Buy
- Analyst Count
- REPL 10
- PSBD 4
- Target Price
- REPL $8.25
- PSBD $14.38
- AVG Volume (30 Days)
- REPL 24.2M
- PSBD 47.9K
- Earning Date
- REPL 08-07-2025
- PSBD 08-06-2025
- Dividend Yield
- REPL N/A
- PSBD 12.66%
- EPS Growth
- REPL N/A
- PSBD N/A
- EPS
- REPL N/A
- PSBD N/A
- Revenue
- REPL N/A
- PSBD N/A
- Revenue This Year
- REPL N/A
- PSBD N/A
- Revenue Next Year
- REPL $194.05
- PSBD N/A
- P/E Ratio
- REPL N/A
- PSBD N/A
- Revenue Growth
- REPL N/A
- PSBD N/A
- 52 Week Low
- REPL $2.68
- PSBD $11.51
- 52 Week High
- REPL $17.00
- PSBD $16.83
- Technical
- Relative Strength Index (RSI)
- REPL 44.05
- PSBD 49.59
- Support Level
- REPL $4.49
- PSBD $13.59
- Resistance Level
- REPL $6.39
- PSBD $14.09
- Average True Range (ATR)
- REPL 0.77
- PSBD 0.34
- MACD
- REPL 0.09
- PSBD 0.01
- Stochastic Oscillator
- REPL 48.77
- PSBD 56.71
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About PSBD Palmer Square Capital BDC Inc.
Palmer Square Capital BDC Inc is a financial services company that lends to and invests in corporate debt securities of companies, including small to large private U.S. companies. Their investment objective is to maximize total return, comprised of current income and capital appreciation.